Profile
Dr. Ted McCluskey is President at Sand Hill Angels, Inc., Principal at BayBio, Advisor at Mission Bay Capital and Stanford SPARK Program on Drug Development.
He also currently serves as a member of the Busniess Advisory Board at Vascular Access Technologies, Inc. and Board of Directors at Sand Hill Angels
Prior to joining Sand Hill Angels in December 2007, Dr. McCluskey was employed as an Advisor by Stanford BioDesign Program, Clinical Consultant by Aviir, Inc., Senior Director by ALZA/Johnson and Johnson and Scios Inc. and Principal by Genentech, Inc.
Dr. McCluskey earned his PhD & MD in Pharmocolgy from Washington University, his undergraduate degree from Stanford University.
Former positions of Ted McCluskey
Companies | Position | End |
---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Sand Hill Angels, Inc.
Sand Hill Angels, Inc. Investment ManagersFinance Sand Hill Angels Inc (Sand Hill Angels) is an angel investment firm founded in 2000. The firm is headquartered in Mountain View, California. | President | - |
Training of Ted McCluskey
University of Washington | Doctorate Degree |
Stanford University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Sand Hill Angels, Inc.
Sand Hill Angels, Inc. Investment ManagersFinance Sand Hill Angels Inc (Sand Hill Angels) is an angel investment firm founded in 2000. The firm is headquartered in Mountain View, California. | Finance |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Ted McCluskey